Guru Ownership Trend
Guru Analysis for Arbutus Biopharma Corporation (ABUS)
Arbutus Biopharma Corporation (ABUS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $8.96 M.
Top institutional holders include Jefferies Group and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $8.63 M net inflow during the quarter.
Recent activity highlights Jefferies Group who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Arbutus Biopharma Corporation (ABUS)
Major holders include Jefferies Group ($8.52 M), Cliff Asness ($107,186), Joel Greenblatt ($77,945). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.94 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $8.63 M, with 3 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in ABUS during the most recent reporting period.
Yes, 2 managers opened new positions in ABUS, and 1 increased their existing holdings. The total reported buy value was $8.63 M.